Charles
Charles has been involved in patient and public involvement in health research for about three years. The majority of his involvement has been in orthopaedic research.
Charles is married and has two grown-up children, aged 44 and 42. He is retired from his job as a research manager. Ethnic background: White British.
More about me...
Charles’s retirement plans changed when his wife developed some health problems. She required serious spinal surgery and later developed memory problems, which meant they had to re-evaluate their plans. When she was in hospital, Charles heard about opportunities for people to get involved in research as lay representatives. He was invited to join a local PPI group after a chance meeting with a former colleague’s wife, who chairs the group.
Since becoming involved in PPI in health research, Charles has been commenting on proposals and writing participant information sheets for research projects. Accurately representing the research requires quite a bit of skill and it is important to get this right as the information sheet is vital for recruiting participants. He is becoming more and more involved in different aspects of health research and has recently been invited to join the James Lind Alliance, which aims to suggest priorities for research.
Charles believes the goal of PPI is to support the NHS, and guide and improve service development and delivery. He thinks it is important to measure the impact of PPI and suggested this could be achieved by indicating what changes have been made as a result of public and patient input. But care needs to be taken to ensure it is captured accurately. Understanding impact will help identify what is going well and what needs to be improved. Assessing the impact of PPI should aim to set standards rather than create regulations.
There are personal benefits to be gained from being involved in PPI and Charles feels he gets a lot from what he does. He finds working with bright people enjoyable and satisfying; he gains knowledge that can be beneficial to his family’s health; and he has found another way to spend his retirement. He thinks anyone can contribute, even people who are strongly critical. To take part, people need free time to devote to it, and an interest in how the health service is run and how care is delivered. He would like researchers to be open-minded to the potential benefits of PPI.
As a retired scientist Charles missed the intellectual contact. He was also interested to find out more about his wife’s condition, and help others
As a retired scientist Charles missed the intellectual contact. He was also interested to find out more about his wife’s condition, and help others
Brilliant thank you very much. Can I just clarify one of the things that you said? You said that the things that you get yourself involved in are personal interests. Is that a personal interest just out of, you know, I'm interested in this type of research or do you think it was linked to your wife's experience?
Oh definitely linked to our own family experience. I sort of feel if this is going on in and around the family then I want to understand what's going on because the more I understand about it, the more comfortable I feel about it, although that's not always the case. But also the more I understand, the better I can contribute. There are other strands as well, you know, there's a strand of altruism that, you know if you can assist a research project then that's good because that's my background. And the other thing is that when I retired one of the things that I really, really missed was the intellectual contact with very good people and although I'm not at all a medic – I'm actually a physical scientist, even a sort of engineer rather, as much a scientist, and I have no medical background – but this brings me back into contact with very bright, very inquisitive, very caring, very conscientious people and I enjoy that contact.
Working with some very bright people has filled a gap in Charles’s life after retirement. It would be ‘icing on the cake’ to learn later about the difference it’s made.
Working with some very bright people has filled a gap in Charles’s life after retirement. It would be ‘icing on the cake’ to learn later about the difference it’s made.
Charles thinks that measuring impact is important but very difficult, and we need to be careful what we measure.
Charles thinks that measuring impact is important but very difficult, and we need to be careful what we measure.
Oh absolutely. It has to be because it, you need to measure things because of the old adage that what gets measured gets done. And if you don't measure things in some way or other then you have no idea whether you're doing well or doing badly. But you need to be very, very careful what you measure otherwise you start setting metrics which distort the provision of the service, and in an ideal world you want an element of coupling of the career success of the service provider at a personal level to the quality of the service which they provide to the service user. You know if you, I don't know, suppose you paid five pounds for every patient who had a flu jab, you could be pretty sure that lots of people would get flu jabs because that's a nice mechanical thing which you can set up and which you can manage. But if you take that the more complicated things, you might want to provide a more expensive treatment on the grounds that it would be a better outcome for the patient and then you wouldn't see that patient again. So it's not just a question of through-putting, how many patients can you get through your door. It's a very, very difficult question, but I think there should be some kind of measurement. If you ask me how, I couldn't answer that question at the moment.
Charles doesn’t like acronyms like ‘PPI’ or the term ‘service user’. ‘Patient representative’ has a clearer meaning.
Charles doesn’t like acronyms like ‘PPI’ or the term ‘service user’. ‘Patient representative’ has a clearer meaning.
Patients can probably be involved in all types of research and they will make a positive difference.
Patients can probably be involved in all types of research and they will make a positive difference.
And are there any types of health research where PPI isn’t useful?
There may be, but nothing springs to mind. I would have thought that there would be a role for PPI actually in every possible field. You know, mental health, paediatric care, cardiac care, all of it. Because, almost by definition in all fields of health provision, there will be people who are drawing on that health provision, and they will have a view on how that care is provided. So I can’t really see… Once a patient is involved, or a member of the public is involved, i.e. once your medical research gets out of the laboratory and is actually being administered to patients or members of the public who are patients, then those people will have a voice and should have a voice.